Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RIMS binding protein 2 (RIMBP2) is a modular adaptor and scaffolding protein found at the presynaptic active zone of neurons, where it links voltage-gated calcium channels and synaptic release machinery to organize and regulate neurotransmitter release[1][2][3][4][5][6]. It features multiple SH3-domains and fibronectin III repeats, supporting its role as a scaffold for coupling Ca²⁺ channel influx with vesicle exocytosis and ensuring precise synaptic signaling[1][2][5]. RIMBP2 is essential for organizing the presynaptic active zone, modulating calcium channel abundance and coupling to release sites, thus influencing release probability and synaptic plasticity[2][4][5][6]. Dysregulation or mutation of RIMBP2 has been linked to various neurological disorders, including Pitt-Hopkins syndrome, specific hereditary deafness, and centronuclear myopathy[3][6]. Despite its critical role in synaptic transmission, RIMBP2 itself is not recognized as a direct therapeutic target for available drugs[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RIMS binding protein 2 (RIMBP2).